{
  "meta": {
    "title": "37_Carcinoma_Pancreas",
    "url": "https://brainandscalpel.vercel.app/37-carcinoma-pancreas-f226685a.html",
    "scrapedAt": "2025-11-30T12:36:05.016Z"
  },
  "questions": [
    {
      "text": "Which of the following statements is false about mucinous cystadenoma of the pancreas?",
      "choices": [
        {
          "id": 1,
          "text": "It is lined by columnar epithelium"
        },
        {
          "id": 2,
          "text": "Commonly seen in peri-menopausal women"
        },
        {
          "id": 3,
          "text": "Identified histologically by the presence of ovarian-like stroma"
        },
        {
          "id": 4,
          "text": "It is not premalignant"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Mucinous cystadenoma</strong>&nbsp;of the pancreas is a&nbsp;<strong>premalignant </strong>condition.</p>\n<p>Mucinous cystadenoma or mucinous cystic neoplasm (MCN) is a <strong>benign</strong> tumor of the pancreas <strong>with high risk of malignancy</strong>. They are commonly seen in <strong>perimenopausal women</strong>, and about <strong>two-thirds</strong> are located in <strong>the body or tail of the pancreas.</strong></p>\n<div class=\"page\" title=\"Page 1438\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>MCNs are mostly&nbsp;<strong>incidental findings</strong>. When symptoms are present, they are usually <strong>nonspecific</strong> and include upper abdominal discomfort, early satiety, or weight loss.</p>\n</div>\n</div>\n</div>\n</div>\n<p>The cysts are <strong>lined by tall columnar epithelium.&nbsp;</strong>MCN's contain <strong>mucin-producing epithelium</strong> and are identified histologically by the presence of <strong>mucin-rich cells and ovarian-like stroma</strong>. Staining for <strong>estrogen and progesterone</strong> is <strong>positive </strong>in most cases.</p>\n<p>Malignant transformation of MCN is&nbsp;<strong>common with large tumors and old patients.</strong>&nbsp;This is due to a stepwise <strong>accumulation of mutations (K-ras, p53).</strong></p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>WHO classification of primary tumors of the pancreas</strong></td>\n</tr>\n<tr>\n<td><strong>Benign</strong></td>\n<td>\n<ul>\n<li>Mucinous cystadenoma</li>\n<li>Serous cystadenoma</li>\n<li>Intraductal papillary mucinous adenoma</li>\n<li>Mature teratoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Borderline</strong></td>\n<td>\n<div class=\"page\" title=\"Page 1438\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Mucinous cystic tumor with moderate dysplasia</li>\n<li>Intraductal papillary mucinous tumor with moderate dysplasia</li>\n<li>Solid pseudopapillary tumor</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Malignant</strong></td>\n<td>\n<ul>\n<li>Ductal adenocarcinoma</li>\n<li>Serous/mucinous cystadenocarcinoma</li>\n<li>Intraductal mucinous papillary tumor</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Cystic Neoplasm of the Pancreas</h3><table>\n<tbody>\n<tr>\n<td><strong>Characteristics</strong></td>\n<td><strong>Serous Cystadenoma</strong></td>\n<td><strong>Mucinous Cystadenoma</strong></td>\n</tr>\n<tr>\n<td>Nature</td>\n<td>Benign</td>\n<td>Benign, but high risk of malignancy</td>\n</tr>\n<tr>\n<td>Epidemiology</td>\n<td>Common in females (F:M = 2:1) and older age&nbsp;<br />Associated with von Hippel Lindau syndrome&nbsp;</td>\n<td>Most common cystic neoplasm of the pancreas&nbsp;<br />Common in perimenopausal females</td>\n</tr>\n<tr>\n<td>Usual site</td>\n<td>\n<p>Usually tail of the pancreas, can be uniformly distributed</p>\n</td>\n<td>Body and tail of the pancreas</td>\n</tr>\n<tr>\n<td>Microscopy</td>\n<td>Microcysts giving a honey-comb appearance Glycogen-rich cells</td>\n<td>Mucin-producing epithelium<br />Ovarian-like stroma<br />Stains positive for estrogen and progesterone</td>\n</tr>\n<tr>\n<td>CT</td>\n<td>Central calcification, with radiating septa giving sunburst appearance.</td>\n<td>\n<p>Solitary cyst with fine septations, surrounded by a rim of calcification.</p>\n<p>Eggshell calcification, large tumor size, or a mural nodule are suggestive of malignancy</p>\n</td>\n</tr>\n<tr>\n<td>Cyst fluid analysis</td>\n<td>\n<p>Mucin negative</p>\n<p>Low CEA and amylase</p>\n</td>\n<td>\n<p>Mucin-rich aspirate</p>\n<p>High CEA and low amylase</p>\n</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>\n<p>Mainly conservative</p>\n<p>Resection: If symptomatic or if malignancy is suspected</p>\n</td>\n<td>Resection (because of risk of malignancy)</td>\n</tr>\n<tr>\n<td>Prognosis</td>\n<td>\n<p>Good</p>\n</td>\n<td>Poor</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7296",
      "difficulty": "easy"
    },
    {
      "text": "A patient with a pancreatic neoplasm undergoes cyst fluid aspiration. The aspirated fluid stains positive for mucin and shows elevated levels of amylase and CEA. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Serous cystadenoma of pancreas"
        },
        {
          "id": 2,
          "text": "Mucinous cystadenoma of pancreas"
        },
        {
          "id": 3,
          "text": "Intraductal papillary mucinous neoplasm"
        },
        {
          "id": 4,
          "text": "Mature cystic teratoma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Positive mucin</strong>&nbsp;staining,&nbsp;<strong>elevated carcinoembryonic antigen</strong>&nbsp;(CEA), and&nbsp;<strong>elevated amylase</strong>&nbsp;levels&nbsp;are seen in cases of&nbsp;<strong>intraductal papillary mucinous neoplasm</strong>&nbsp;(IPMN).</p>\n<p>Cyst fluid analysis of various pancreatic cystic neoplasms:</p>\n<table>\n<tbody>\n<tr>\n<td>Characteristics</td>\n<td><strong>Serous cystic neoplasm (SCN)</strong></td>\n<td><strong>Mucinous cystic neoplasm (MCN)</strong></td>\n<td><strong>Intraductal papillary mucinous neoplasm (IPMN)</strong></td>\n</tr>\n<tr>\n<td><strong>Cytology</strong></td>\n<td>\n<div class=\"page\" title=\"Page 1565\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Scant glycogen-rich cells, with positive periodic acid&ndash;Schiff stain</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 1565\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Sheets and clusters of columnar, mucin-containing cells</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 1565\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Tall, columnar, mucin-containing cells</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Mucin stain</strong></td>\n<td>Negative</td>\n<td>Positive</td>\n<td>Positive</td>\n</tr>\n<tr>\n<td><strong>Amylase</strong></td>\n<td>Low</td>\n<td>Low</td>\n<td>High</td>\n</tr>\n<tr>\n<td><strong>CEA</strong></td>\n<td>Low</td>\n<td>High</td>\n<td>High</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7300",
      "difficulty": "medium"
    },
    {
      "text": "A 58-year-old man is being evaluated for recurrent attacks of pancreatitis. An ERCP is done and it shows the presence of a fish-mouth sign at the ampulla of Vater. Which of the following statements is true about his condition?",
      "choices": [
        {
          "id": 1,
          "text": "It is more common in males"
        },
        {
          "id": 2,
          "text": "It only involves the main pancreatic duct"
        },
        {
          "id": 3,
          "text": "Head of pancreas is most common site of the neoplasm"
        },
        {
          "id": 4,
          "text": "They have no malignant potential"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>A<strong>&nbsp;fish mouth sign&nbsp;</strong>at the ampulla of Vater during<strong>&nbsp;ERCP</strong>&nbsp;is indicative of&nbsp;<strong>intraductal papillary mucinous neoplasm&nbsp;(IPMN).&nbsp;</strong>It&nbsp;is most commonly seen in the <strong>head of the pancreas.</strong></p>\n<p>The&nbsp;intraductal papillary mucinous neoplasm can be diagnosed with the following findings (<strong>Ohashi triad</strong>) during endoscopy:</p>\n<ul>\n<li>Bulging ampulla of Vater (<strong>fish-mouth sign</strong>)</li>\n<li>Dilated pancreatic duct</li>\n<li>Mucin secretion from the opening</li>\n</ul>\n<p><strong>Equal distribution</strong> is seen between males and females in IPMN.<strong><strong>&nbsp;</strong></strong>Patients are usually in their <strong>seventh or eighth decade of life</strong> and present with <strong>abdominal pain</strong> or <strong>recurrent pancreatitis</strong>. This is caused by the <strong>obstruction of the pancreatic duct</strong> by thick mucin. Some patients have symptoms secondary to <strong>pancreatic insufficiencies</strong> like steatorrhea, diabetes, and weight loss.</p>\n<p>IMPNs are of three types:</p>\n<ul>\n<li><strong>Branch-duct IPMN</strong> (BD-IPMN) - affects only the small<strong> side branches. </strong>It is less frequently associated with malignancy.</li>\n<li><strong>Main duct IPMN</strong> (MD-IPMN) - Affects the <strong>main pancreatic duct. </strong>Malignant transformation is commonly seen.</li>\n<li><strong>Mixed-type IPMN -&nbsp;</strong>side-branch IPMNs that extend into the main duct&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7299",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old man was incidentally found to have a pancreatic lesion on a USG. On further evaluation, a CT scan revealed the presence of a multicystic, lobulated mass in the pancreatic head, suggestive of serous cystadenoma. He is currently asymptomatic. What will be the next step in the management of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Repeat CT scan after 6 months"
        },
        {
          "id": 2,
          "text": "Resection of the tumor"
        },
        {
          "id": 3,
          "text": "Endoscopic ultrasound guided FNA"
        },
        {
          "id": 4,
          "text": "Diagnostic laparoscopy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Endoscopic ultrasound-guided FNA</strong>&nbsp;(EUS-FNA) will be the next step in the management of this patient.</p>\n<div class=\"page\" title=\"Page 1437\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Serous cystadenomas</strong> are essentially <strong>benign tumors</strong> without malignant potential. Serous cystadenocarcinoma has been reported very rarely (&lt;1%). Therefore, malignant potential should not be a consideration for surgical resection. <strong>Surgical resection</strong> is done only for <strong>symptomatic</strong> patients.</p>\n<div class=\"page\" title=\"Page 1438\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>In <strong>asymptomatic</strong> patients, <strong>conservative </strong>management is adopted. However, it is important to confirm the diagnosis using <strong>EUS-FNA</strong>. It yields a <strong>non-viscous fluid</strong> with <strong>low CEA and amylase</strong> levels.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<p>Algorithm for management of pancreatic cystic neoplasms:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b29d7d4a0f8a49c799fdcd287064bb5bx1280x2560.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7301",
      "difficulty": "medium"
    },
    {
      "text": "What is the initiating event in the oncogenesis of pancreatic cancers?",
      "choices": [
        {
          "id": 1,
          "text": "Activation of K-ras 2"
        },
        {
          "id": 2,
          "text": "Loss of p16 function"
        },
        {
          "id": 3,
          "text": "p53 mutation"
        },
        {
          "id": 4,
          "text": "Loss of DPC4 function"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>activation of the K-ras 2</strong> oncogene is the <strong>initiating event</strong> in the oncogenesis of <strong>pancreatic cancers</strong>. It is activated in <strong>more than 95%</strong> of pan&shy;creatic cancers.</p>\n<p><strong>Pancreatic intraepithelial neoplasia</strong> (PanIN) develops into <strong>pancreatic ductal adenocarcinoma</strong> (PDAC) in a sequential pathway. A number of tumor suppressor genes and oncogenes play a significant role in the pathogenesis of PDAC. They include:</p>\n<ul>\n<li>K-ras 2</li>\n<li>PDX1</li>\n<li>CDKN2A/p16</li>\n<li>p53</li>\n<li>DPC4 (SMAD4)</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0718ca21e1614634b91197a6e481772dx1280x1007.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7302",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following are not risk factors for the development of pancreatic cancer?<div class='question-desc-html'><ol>\n<li>History of acute pancreatitis</li>\n<li>Long-standing diabetes mellitus</li>\n<li>BRCA2 mutation</li>\n<li>Female gender</li>\n<li>Cigarette smoking</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 4"
        },
        {
          "id": 2,
          "text": "1 and 5"
        },
        {
          "id": 3,
          "text": "2 and 3"
        },
        {
          "id": 4,
          "text": "3 and 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>An history of acute pancreatitis&nbsp;and female gender are&nbsp;<strong>not </strong>risk factors for the development of pancreatic cancer.</p>\n<p>Risk factors for pancreatic cancer:</p>\n<ul>\n<li>Demographic factors:\n<ul>\n<li>Age (peak incidence, 65&ndash;75 years)</li>\n<li><strong>Male gender</strong></li>\n<li>Black ethnicity</li>\n</ul>\n</li>\n<li><strong>Cigarette smoking</strong></li>\n<li>Genetic factors and medical conditions</li>\n<li>Family history:\n<ul>\n<li>Two first-degree relatives with pancreas cancer</li>\n<li>Germline <strong><em>BRCA2</em> mutations</strong> in some rare high-risk families</li>\n</ul>\n</li>\n<li><strong>Hereditary pancreatitis</strong></li>\n<li><strong>Chronic pancreatitis</strong></li>\n<li>Lynch syndrome</li>\n<li>Ataxia telangiectasia</li>\n<li>Peutz&ndash;Jeghers syndrome</li>\n<li>Familial breast-ovarian cancer syndrome</li>\n<li>Familial adenomatous polyposis&nbsp;</li>\n<li><strong>Diabetes mellitus</strong></li>\n<li>Obesity&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7303",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common type of pancreatic malignancy?",
      "choices": [
        {
          "id": 1,
          "text": "Squamous cell carcinoma"
        },
        {
          "id": 2,
          "text": "Adenocarcinoma"
        },
        {
          "id": 3,
          "text": "Insulinoma"
        },
        {
          "id": 4,
          "text": "Acinar cell carcinoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Ductal adenocarcinoma</strong> is the most common type of pancreatic cancer.</p>\n<p>Types of exocrine pancreatic cancer:</p>\n<ul>\n<li>Ductal adenocarcinoma (85%)</li>\n<li>Adenosquamous carcinoma</li>\n<li>Acinar cell carcinoma</li>\n</ul>\n<p>Endocrine cancer of the pancreas is rare. They account for only 5% of clinically detected pancreatic tumours.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7304",
      "difficulty": "easy"
    },
    {
      "text": "What is the most common site for pancreatic carcinoma?",
      "choices": [
        {
          "id": 1,
          "text": "Head"
        },
        {
          "id": 2,
          "text": "Neck"
        },
        {
          "id": 3,
          "text": "Body"
        },
        {
          "id": 4,
          "text": "Tail"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Pancreatic carcinomas&nbsp;</strong>arise most commonly from the&nbsp;<strong>head </strong>of the gland.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7305",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is false regarding the presentation of patients with pancreatic carcinoma?",
      "choices": [
        {
          "id": 1,
          "text": "Release of platelet aggregating factors cause migratory thrombophlebitis"
        },
        {
          "id": 2,
          "text": "Abdominal pain is the most common presentation"
        },
        {
          "id": 3,
          "text": "Courvoisier's law implicates possible cancer of the head of the pancreas"
        },
        {
          "id": 4,
          "text": "Tumors of the body present at an advanced unresectable stage"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Jaundice</strong> is the most common presentation of <strong>carcinoma of the head of the pancreas</strong>.&nbsp;It is secondary to <strong>obstruction of the distal bile duct</strong>.</p>\n<div class=\"page\" title=\"Page 1255\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Clinical features of pancreatic cancers:</p>\n<ul>\n<li><strong>Jaundice</strong> (most common)</li>\n<li>Nausea</li>\n<li>Epigastric discomfort</li>\n<li>Pruritus, dark urine, pale stools</li>\n<li>Steatorrhea</li>\n<li>Anorexia</li>\n<li>Weight loss</li>\n<li>Back pain - indicates retroperitoneal infiltration</li>\n</ul>\n<p>On examination, the patient can have:</p>\n<ul>\n<li>Palpable abdominal mass</li>\n<li>Ascites</li>\n<li>Supraclavicular lymphnodes</li>\n<li>Migratory superficial thrombophlebitis (<strong>Trousseau&rsquo;s sign of malignancy</strong>) - due to release of <strong>platelet aggregating factors</strong> from the tumor</li>\n<li>Secondaries in the rectovesical pouch (<strong>Blumer&rsquo;s shelf</strong>)</li>\n<li>A palpable, non-tender gall bladder</li>\n</ul>\n<p><strong>Courvoisier's law</strong>&nbsp;states that in the presence of a <strong>painless</strong>, <strong>palpable</strong>, <strong>enlarged gallbladder</strong> and mild <strong>jaundice</strong>,&nbsp;the cause is <strong>unlikely to be gallstones</strong>. This sign implicates possible cancer of the head of the pancreas.</p>\n</div>\n</div>\n</div>\n</div>\n<p>Tumors of the <strong>body and tail</strong> of the gland often <strong>grow silently</strong> and present at an advanced unresectable stage.</p>\n<p>Image showing migratory superficial thrombophlebitis (Trousseau&rsquo;s sign of malignancy):</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1d5e42bd33194f92bdfbe260ecfece06x720x990.PNG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Note:&nbsp;<strong>Trousseau's sign</strong>&nbsp;is also seen in <strong>hypocalcemia</strong>. It indicates <strong>carpopedal spasm</strong> (finger and wrist spasm) after inflation of a blood pressure cuff for several minutes when the brachial artery is occluded.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7306",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is not true about pancreatic ductal adenocarcinoma?",
      "choices": [
        {
          "id": 1,
          "text": "It is associated with desmoplastic changes, with scattering of neoplastic glands"
        },
        {
          "id": 2,
          "text": "Perineural invasion is characteristic"
        },
        {
          "id": 3,
          "text": "Body tumors are smaller"
        },
        {
          "id": 4,
          "text": "Carcinoma of the head of the pancreas causes obstruction of both the pancreatic and biliary ducts"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Pancreatic ductal adenocarcinomas </strong>situated in the <strong>body of the pancreas</strong> are usually <strong>larger.</strong></p>\n<p>Pancreatic adenocarcinomas are <strong>solid, slow-growing tumors</strong>, characterized by neoplastic tubular glands within a markedly <strong>desmoplastic fibrous stroma</strong>. They <strong>infiltrate locally,</strong> typically along nerve sheaths, along lymphatics, and into blood vessels.</p>\n<p>Carcinoma of the head of the pancreas causes<strong> obstruction</strong> of both the pancreatic and biliary ducts.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7307",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old man with a history of chronic pancreatitis presents with jaundice, severe itching, and weight loss. A smooth, globular mass is palpable in the right upper quadrant of the abdomen. You suspect pancreatic cancer. What will be the imaging modality of choice for the evaluation of the tumor?",
      "choices": [
        {
          "id": 1,
          "text": "Endoscopic retrograde cholangiopancreatography"
        },
        {
          "id": 2,
          "text": "Magnetic resonance cholangiopancreatography"
        },
        {
          "id": 3,
          "text": "Multidetector CT scan"
        },
        {
          "id": 4,
          "text": "PET scan"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Multidetector computed tomography </strong>(CT) is the <strong>imaging</strong> <strong>modality of choice</strong> for the evalua&shy;tion of <strong>pancreatic tumors</strong>. It allows an accurate determination of the level of biliary obstruction, the relationship of the tumor to the blood vessels, and the presence of regional or metastatic disease.</p>\n<div class=\"page\" title=\"Page 1571\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>For a detailed assessment of the luminal <strong>pancreato-biliary anatomy</strong>, <strong>MRCP</strong> should be considered.&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 1571\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>ERCP</strong> is reserved for cases requiring therapeutic or palliative intervention. It helps&nbsp;to perform a <strong>biopsy</strong> and to relieve obstruction by <strong>biliary stenting</strong>. The invasiveness of ERCP increases the rate of <strong>wound infection</strong>. Hence, it is not suitable for patients who will be undergoing surgery.</p>\n<div class=\"page\" title=\"Page 1571\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 1571\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>F-fluorodeoxyglucose positron emission tomography (<strong>FDG-PET</strong>) has the ability to differentiate between benign and malignant pancreas tumors. However, <strong>false-positive results </strong>are seen in&nbsp;FDG-PET. The benefits of FDG-PET over CT scans are yet to be determined.</p>\n<p>A CT-scan of pancreatic cancer:</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a1ef7d3cce8d43a2b0aadc3d651c0e7ax720x581.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7308",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a radiological sign that is not seen in patients with adenocarcinoma of the pancreas?",
      "choices": [
        {
          "id": 1,
          "text": "Scrambled egg appearance"
        },
        {
          "id": 2,
          "text": "Inverse 3 sign"
        },
        {
          "id": 3,
          "text": "Double duct appearance"
        },
        {
          "id": 4,
          "text": "Narrowing of C-loop of the duodenum"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Widening of the C-loop</strong> of the duodenum is a <strong>barium meal</strong> finding seen in the <strong>adenocarcinoma of the pancreas</strong>.</p>\n<p>Radiological features of adenocarcinoma pancreas:</p>\n<p>Endoscopic retrograde cholangiopancreatography (ERCP) findings:</p>\n<ul>\n<li>Scrambled egg appearance</li>\n<li>Double duct appearance</li>\n</ul>\n<p>Barium meal findings:</p>\n<ul>\n<li>Inverse 3 sign</li>\n<li>Rose thorning of 2<sup>nd</sup> part of the duodenum</li>\n<li>Widened duodenal C-loop</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7309",
      "difficulty": "medium"
    },
    {
      "text": "The best method to obtain tissue for the diagnosis of pancreatic carcinoma is:",
      "choices": [
        {
          "id": 1,
          "text": "Transgastric FNAC guided by endoscopic ultrasound"
        },
        {
          "id": 2,
          "text": "MRI-guided biopsy"
        },
        {
          "id": 3,
          "text": "Laparoscopic-guided biopsy"
        },
        {
          "id": 4,
          "text": "Percutaneous transperitoneal biopsy"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Transgastric or transduodenal FNAC</strong> or <strong>trucut biopsy</strong> performed under<strong> endoscopic ultrasound (EUS)</strong> guidance is the best method to obtain tissue for the diagnosis of <strong>pancreatic carcinoma</strong>. This is because it <strong>avoids the spillage</strong> of tumor cells into the peritoneal cavity.&nbsp;</p>\n<p>Endoscopic ultrasonography with a fine needle aspiration <strong>(EUS-FNA)</strong> is done if CT has failed to demonstrate a tumor. When a tissue diagnosis is required prior to surgery to distinguish between inflammation and neoplasia, EUS-FNA is helpful.</p>\n<div class=\"page\" title=\"Page 1256\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Diagnostic laparoscopy</strong> prior to resection can spare an unnecessary laparotomy by identifying small peritoneal and liver metastases.</p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Percutaneous transperitoneal biopsy</strong> of potentially resectable pancreatic tumors is&nbsp;<strong>avoided.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3788",
      "difficulty": "medium"
    },
    {
      "text": "Which is the most reliable tumor marker for the pre-treatment evaluation of a patient with pancreatic adenocarcinoma?",
      "choices": [
        {
          "id": 1,
          "text": "Carcinoembryonic antigen"
        },
        {
          "id": 2,
          "text": "CA 19-9"
        },
        {
          "id": 3,
          "text": "Alpha-fetoprotein"
        },
        {
          "id": 4,
          "text": "CA 15-3"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Carbohydrate antigen (CA) 19-9</strong>&nbsp;is the <strong>most reliable tumor marker</strong> for pretreatment evaluation and post-treatment surveillance of <strong>pancreatic adenocarcinoma</strong>.</p>\n<p>Other tumor markers for pancreatic carcinoma are <strong>carcinoembryonic antigen</strong> (CEA) and <strong>&alpha;-fetoprotein</strong>.</p><hr><h3>Related Pearl: Tumor Markers</h3><p><strong>Tumor Markers</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Tumor Markers</strong></p>\n</td>\n<td>\n<p><strong>Tumor Types</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hormones</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human chorionic gonadotropin</p>\n</td>\n<td>\n<p>Trophoblastic tumors, nonseminonmatous testicular tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Calcitonin</p>\n</td>\n<td>\n<p>Medullary carcinoma of thyroid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Catecholamine and metabolites</p>\n</td>\n<td>\n<p>Pheochromocytoma and related tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Oncofetal Antigens</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&alpha;-Fetoprotein</p>\n</td>\n<td>\n<p>Liver cell cancer, nonseminonmatous germ-cell tumors of the&nbsp;testis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoembryonic antigen</p>\n</td>\n<td>\n<p>Carcinomas of the colon, lung, stomach, and heart</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Enzymes</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic acid phosphatase</p>\n</td>\n<td>\n<p>Prostate cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neuron-specific enolase</p>\n</td>\n<td>Small-cell cancer of the lung, neuroblastoma</td>\n</tr>\n<tr>\n<td>\n<p>Lactate dehydrogenase (LDH)</p>\n</td>\n<td>Germ-cell tumors, lymphomas, leukemias</td>\n</tr>\n<tr>\n<td>Thymidine kinase</td>\n<td>Leukemias</td>\n</tr>\n<tr>\n<td>Pyruvate kinase</td>\n<td>Renal cell carcinoma</td>\n</tr>\n<tr>\n<td>Placental alkaline phosphatase</td>\n<td>Seminoma</td>\n</tr>\n<tr>\n<td>\n<p><strong>Specific Proteins</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Immunoglobulins</p>\n</td>\n<td>\n<p>Multiple myeloma and other gammopathies</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostate-specific antigen and prostate- specific membrane antigen</p>\n</td>\n<td>\n<p>Prostate cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NMP 22</p>\n</td>\n<td>\n<p>Bladder cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mucins and Other Glycoproteins</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA-125</p>\n</td>\n<td>\n<p>Ovarian cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA- 19-9</p>\n</td>\n<td>\n<p>Colon cancer, pancreatic cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA-15-3</p>\n</td>\n<td>\n<p>Breast cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cell-Free DNA markers</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, APC, RAS</em> mutants in stool and serum</p>\n</td>\n<td>\n<p>Colon cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, RAS</em> mutants in stool and serum</p>\n</td>\n<td>\n<p>Pancreatic cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, RAS</em> mutants in sputum and serum</p>\n</td>\n<td>\n<p>Lung cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53</em> mutants in urine</p>\n</td>\n<td>\n<p>Bladder cancer</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>NMP: Nuclear matrix protein</p>\n<p>CA: Carbohydrate antigen</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7310",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old man has been diagnosed with pancreatic cancer. In order to diagnose a resectability status, a CECT abdomen is performed. Which of the following features will indicate an unresectable tumor?",
      "choices": [
        {
          "id": 1,
          "text": "Abutment of superior mesenteric artery"
        },
        {
          "id": 2,
          "text": "Stage II cancer on AJCC staging criteria"
        },
        {
          "id": 3,
          "text": "Short segment occlusion of superior mesenteric vein"
        },
        {
          "id": 4,
          "text": "Encasement of celiac artery"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Encasement of the celiac artery ( i.e &gt;180&deg; or &gt;50% of the vessel circumference involvement) indicates surgical inoperability and is therefore considered to be non-resectable.</p>\n<p><strong>Varadhachary- Katz criteria</strong> for resectability of pancreatic cancer:</p>\n<table>\n<tbody>\n<tr>\n<td>Criteria</td>\n<td>\n<p>Resectable</p>\n<p>(if all are satisfied)</p>\n</td>\n<td>\n<p>Borderline resectable</p>\n<p>(if any one is satisfied)</p>\n</td>\n<td>\n<p>Unresectable</p>\n<p>(if any one is satisfied)</p>\n</td>\n</tr>\n<tr>\n<td>AJCC stage</td>\n<td>I/II</td>\n<td>III</td>\n<td>III</td>\n</tr>\n<tr>\n<td>SMA</td>\n<td>Not affected</td>\n<td>Abutment</td>\n<td>Encasement</td>\n</tr>\n<tr>\n<td>Celiac axis</td>\n<td>Not affected</td>\n<td>Abutment</td>\n<td>Encasement</td>\n</tr>\n<tr>\n<td>CHA</td>\n<td>Not affected</td>\n<td>Abutment</td>\n<td>Encasement</td>\n</tr>\n<tr>\n<td>SMV-PV</td>\n<td>Patent</td>\n<td>Short segment occlusion</td>\n<td>Long segment occlusion</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p>Note: Any evidence of peritoneal seeding, malignant ascites, or distant metastasis also indicates an unresectable tumor.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>SMA: superior mesenteric artery, CHA: common hepatic artery, SMV-PV: superior mesenteric vein-portal vein confluence</p>\n<p>Definitions:</p>\n<ul>\n<li aria-level=\"2\"><strong>Abutment</strong> means <strong>&le;180&deg;</strong> or &le;50% of the vessel circumference involvement;&nbsp;</li>\n<li aria-level=\"2\"><strong>Encasement</strong> means <strong>&gt;180&deg;</strong> or &gt;50% of the vessel circumference&nbsp; involvement</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4282",
      "difficulty": "medium"
    },
    {
      "text": "A patient presents to the OPD with complaints of jaundice, clay-colored stools, and pruritis. After detailed radiological and pathological investigations, a 2 cm adenocarcinoma is found at the head of the pancreas. There is no spread to the adjacent structures. What is the preferred surgical management in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Whipple’s procedure"
        },
        {
          "id": 2,
          "text": "Pylorus preserving pancreaticoduodenectomy"
        },
        {
          "id": 3,
          "text": "Duodenum-preserving pancreatic head resection"
        },
        {
          "id": 4,
          "text": "Puestow's procedure"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Since there is no involvement of adjacent structures, the preferred surgical management in this patient is&nbsp;<strong>pylorus-preserving pancreatoduodenectomy (PPPD), </strong>also known as <strong>Longmire&ndash;Traverso procedure</strong>.</p>\n<p>Pylorus-preserving pancreatoduodenectomy (PPPD)&nbsp;involves the&nbsp;removal of:</p>\n<ul>\n<li>Duodenum&nbsp;</li>\n<li>Pancreatic head</li>\n<li>The distal part of the bile duct</li>\n</ul>\n<p>The<strong>&nbsp;original pancreatoduodenectomy</strong>, as proposed by <strong>Whipple</strong>, included <strong>resection of the gastric antrum</strong>.</p>\n<p><strong>Preserving the antrum</strong> <strong>and the pylorus</strong>&nbsp;results in a <strong>better physiological outcome</strong>, with no difference in survival or recurrence rates. Hence PPPD is preferred.</p>\n<p>For tumors of the <strong>body and tail</strong>, <strong>distal pancreatectomy</strong>&nbsp;is the preferred surgical management.</p>\n<p><strong>Duodenum-preserving pancreatic head resection</strong> (Beger's procedure) and <strong>Puestow's procedure</strong> (resection of tail followed by longitudinal pancreaticojejunostomy) are management options for <strong>chronic pancreatitis</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7311",
      "difficulty": "medium"
    },
    {
      "text": "You assist in performing a Whipple procedure in a patient with carcinoma of the pancreas. All of the following structures will be resected in this surgery, except:<div class='question-desc-html'><ol>\n<li>Gallbladder</li>\n<li>Common bile duct</li>\n<li>Spleen</li>\n<li>Proximal jejunum</li>\n<li>Tail of the pancreas</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 3"
        },
        {
          "id": 2,
          "text": "2 and 4"
        },
        {
          "id": 3,
          "text": "3 and 5"
        },
        {
          "id": 4,
          "text": "4 and 5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Whipple procedure does <strong>not</strong> involve the removal of the spleen and tail of the pancreas.</p>\n<p>The <strong>Whipple procedure</strong> is a complex surgery done for carcinomas involving the <strong>head of the pancreas</strong>. It is done only in cases when:</p>\n<ul>\n<li>The entire duodenum has to be removed e.g. in familial adenomatous polyposis (FAP)</li>\n<li>Tumor encroaches in the first part of the duodenum, or stomach</li>\n<li>A clear resection margin is not achieved by pylorus preserving pancreatoduodectomy</li>\n</ul>\n<p>The following structures are removed during Whipple’s procedure:</p>\n<ul>\n<li>Distal stomach</li>\n<li>Duodenum</li>\n<li>Proximal jejunum</li>\n<li>Head of the pancreas</li>\n<li>Gallbladder</li>\n<li>Common bile duct (CBD)</li>\n<li>Regional lymphatics</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/07f48a57633d4d77906091f13eac1771x1280x2559.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7312",
      "difficulty": "easy"
    },
    {
      "text": "During the reconstruction of the Whipple procedure, all of the following anastomoses will be done by a surgeon except:",
      "choices": [
        {
          "id": 1,
          "text": "Pancreaticojejunostomy"
        },
        {
          "id": 2,
          "text": "Ileojejunostomy"
        },
        {
          "id": 3,
          "text": "Choledochojejunostomy"
        },
        {
          "id": 4,
          "text": "Gastrojejunostomy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Ileojejunostomy will <strong>not</strong> be done during the reconstruction of the Whipple procedure.</p>\n<p>The <strong>reconstruction following Whipple&rsquo;s procedure</strong> or pylorus-preserving pancreaticoduodenectomy involves anastomosis in the following order:</p>\n<p>Pancreati&shy;cojejunostomy</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &darr;</p>\n<p>Choledochojejunostomy</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &darr;</p>\n<p>Gastrojejunostomy</p><p>This is <strong>controversial</strong> since there is a difference in the reconstruction procedures mentioned in standard textbooks:</p>\n<p>Bailey and Love, 27th edition (Pg no: 1236) - Pancreaticojejunostomy + choledechojejunostomy + duodenojejunostomy&nbsp;<br /><br />Schwatrz, 11th edition (Pg no: 1493) - Pancreaticojejunostomy + choledechojejunostomy + gastrojejunostomy/duodenojejunostomy<br /><br />Sabiston, 20th edition (Pg no: 1546) - Pancreaticojejunostomy + hepaticojejunostomy + duodenojejunostomy</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2f0d0ddf66894823ba8e298d90cd04b9x1280x2559.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7316",
      "difficulty": "easy"
    },
    {
      "text": "During the Whipple procedure, a surgeon performs the Kocher maneuver to access the retroperitoneum. This maneuver involves:",
      "choices": [
        {
          "id": 1,
          "text": "Mobilization of gall bladder"
        },
        {
          "id": 2,
          "text": "Mobilization of second part of duodenum"
        },
        {
          "id": 3,
          "text": "Mobilization of the pancreas"
        },
        {
          "id": 4,
          "text": "Mobilization of ascending colon"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The<strong> Kocher maneuver</strong> involves the mobilization of the <strong>second part of the duodenum. </strong>It allows exposure of the retroperitoneal fat and the inferior vena cava (IVC).</p>\n<p>Another maneuver that is used to access the retroperitoneum is the&nbsp;<strong>Cattel Braasch maneuver</strong>. It involves the mobilization of the <strong>ascending colon.</strong></p>\n<p>Other Kocher's in medicine:</p>\n<ul>\n<li>Kocher's technique is used for the reduction of <strong>anterior shoulder dislocation</strong>. It involves four steps:<br />Traction &rarr; External Rotation &rarr; Adduction &rarr; Medial Rotation (TEAM)</li>\n<li>During <strong>thyroid palpation</strong>, Kocher's method is done to demonstrate the <strong>pressure effect</strong> of the thyroid gland on the trachea or larynx. <strong>Lateral compression</strong> will result in stridor.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7313",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false regarding complications of the Whipple procedure?",
      "choices": [
        {
          "id": 1,
          "text": "Delayed gastric emptying is characterized by the need for prolonged nasogastric decompression"
        },
        {
          "id": 2,
          "text": "Endocrine insufficiency is a complication"
        },
        {
          "id": 3,
          "text": "Any drainage output on or after postoperative day 3, with amylase >3 times normal value indicates pancreatic fistula"
        },
        {
          "id": 4,
          "text": "Biliary leakage is the most common complication"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Delayed gastric emptying</strong> is the most common complication following the&nbsp;<strong>Whipple procedure,&nbsp;</strong>not biliary leakage.</p>\n<p>Delayed gastric emptying is characterized by the need for prolonged nasogastric decompression or the inability to tolerate oral intake.&nbsp;</p>\n<p>Most pancreatic fistulas are controlled by drainage catheters placed at the time of surgery. A <strong>pancreatic leak or pancreatic fistula</strong> is defined as the output via an intraoperatively placed drain (or percutaneous drain) of any measurable volume on or after <strong>postoperative day 3</strong>, with <strong>amylase &gt;3 times the normal value</strong>.&nbsp;</p>\n<p>Other complications of the Whipple procedure include:</p>\n<ul>\n<li>Wound infection</li>\n<li>Intra-abdominal abscess</li>\n<li>Cardiac events</li>\n<li>Bile leak</li>\n<li>Overall reoperation</li>\n<li>Exocrine insufficiency</li>\n<li>Endocrine insufficiency</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7314",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common cause of death in patients following pancreaticoduodenectomy?",
      "choices": [
        {
          "id": 1,
          "text": "Cardiopulmonary complications"
        },
        {
          "id": 2,
          "text": "Gastric outlet obstruction"
        },
        {
          "id": 3,
          "text": "Anastomotic leakage"
        },
        {
          "id": 4,
          "text": "Haemorrhage"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The most common cause of death following <strong>pancreaticoduodenectomy</strong> is sepsis due to<strong> anastomotic leakage.</strong></p>\n<p>Anastomotic leakage is responsible for 33&ndash;88 % of postoperative deaths after pancreaticoduodenectomy. Only about 5&ndash;16 % of patients develop post-surgical bleeding complications.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7317",
      "difficulty": "medium"
    },
    {
      "text": "A patient was found to have a 3 cm adenocarcinoma of the body of the pancreas invading into the superior mesenteric artery. All of the following chemotherapeutic agents can be utilized for the management of this patient except:",
      "choices": [
        {
          "id": 1,
          "text": "FOLFIRINOX regimen"
        },
        {
          "id": 2,
          "text": "Albumin-bound paclitaxel"
        },
        {
          "id": 3,
          "text": "MVAC regimen"
        },
        {
          "id": 4,
          "text": "Gemcitabine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>MVAC regimen </strong>(methotrexate, vinblastine, adriamycin, and cisplatin) is not used in the management of this patient. MVAC regimen is used in&nbsp;<strong>advanced bladder carcinoma.</strong></p>\n<p><strong>Chemotherapy</strong> in pancreatic cancer is indicated in patients with <strong>unresectable tumours</strong> and lymph node metastasis. Agents used in chemotherapy are:</p>\n<ul>\n<li>Gemcitabine</li>\n<li>Gemcitabine with capecitabine</li>\n<li>Albumin bound paclitaxel (nab-paclitaxel)</li>\n<li>FOLFIRINOX - a combination of fluorouracil, irinotecan, oxaliplatin, and leucovorin</li>\n</ul>\n<p>However, there is only a <strong>2&ndash;5 months increase in median survival</strong> with these regimens. <strong>No long-term cure</strong>&nbsp;is seen with chemotherapy or radiotherapy for pancreatic carcinomas.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7320",
      "difficulty": "medium"
    }
  ]
}